Prejunctional effects of angiotensin II and bradykinin in the heart and blood vessels

Citation
D. Moura et al., Prejunctional effects of angiotensin II and bradykinin in the heart and blood vessels, J AUT PHARM, 19(6), 1999, pp. 321-325
Citations number
37
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF AUTONOMIC PHARMACOLOGY
ISSN journal
01441795 → ACNP
Volume
19
Issue
6
Year of publication
1999
Pages
321 - 325
Database
ISI
SICI code
0144-1795(199912)19:6<321:PEOAIA>2.0.ZU;2-W
Abstract
1 Angiotensin and bradykinin facilitate the release of noradrenaline from s ympathetic nerve terminals and cause positive inotropy in rat isolated atri a and ventricles. The effect of bradykinin was enhanced by the ACE inhibito r, ramiprilat. 2 The facilitated release of noradrenaline in rat ventricle by bradykinin w as blocked by the beta(2)-receptor antagonist HOE-140. This response is als o reduced by removing the endocardium, suggesting the release of a mediator from the endocardium. 3 The facilitated noradrenaline release by angiotensin II and bradykinin wa s blocked by the angiotensin receptor antagonist saralasin to the same exte nt. In contrast, losartan caused only minor blockade in a range of vascular and cardiac tissues. This suggests that angiotensin and bradykinin exert t hese responses by interacting with a prejunctional receptor different from the established AT(1) subtype. 4 These results suggest that bradykinin mediates facilitation of noradrenal ine release via the local release of angiotensin onto an atypical AT(1) rec eptor.